Talk:Ceftazidime/avibactam
Appearance
This is the talk page for discussing improvements to the Ceftazidime/avibactam article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Ceftazidime/avibactam.
|
Needs clarification
[edit]"The combination was approved for medical use in the United States and the European Union in 2015.", while "It was granted approval for marketing in the United States by the Food and Drug Administration (FDA) in February 2015. It was granted approval for marketing in Europe by the European Medicines Agency in 2016" Are these 2 expressions conflicting or what? Thanks for you kind attention. ThomasYehYeh (talk) 02:23, 14 July 2024 (UTC)